Susan R. Keyes
About
In The Last Decade
Susan R. Keyes
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Clinical Psychology 434
- Molecular Biology 337
- Epidemiology 167
- Toxicology 149
- Social Psychology 147
Countries citing papers authored by Susan R. Keyes
This map shows the geographic impact of Susan R. Keyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan R. Keyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan R. Keyes more than expected).
Fields of papers citing papers by Susan R. Keyes
This network shows the impact of papers produced by Susan R. Keyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan R. Keyes. The network helps show where Susan R. Keyes may publish in the future.
Co-authorship network of co-authors of Susan R. Keyes
This figure shows the co-authorship network connecting the top 25 collaborators of Susan R. Keyes. A scholar is included among the top collaborators of Susan R. Keyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan R. Keyes. Susan R. Keyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Resunga, the mountain of the horned sage : two districts in central Nepal | 1 |
| 2 | 42 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 16 | |
| 6 | Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. | 44 |
| 7 | 280 | |
| 8 | 39 | |
| 9 | 354 | |
| 10 | Preclinical studies of porfiromycin as an adjunct to radiotherapy. | 51 |
| 11 | 8 | |
| 12 | 10 | |
| 13 | Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. | 56 |
| 14 | 49 | |
| 15 | Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. | 65 |
| 16 | Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. | 159 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.